Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Transjugular intrahepatic portosystemic shunt or paracentesis for refractory ascites—which is best?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 312–313 (2006)Cite this article

boxed-textAlbillos A et al. (2005) A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites. J Hepatol 43: 990–996

Transjugular intrahepatic portosystemic shunt is an effective therapy for patients with refractory ascites; however, clinicians should weigh up the risks and benefits for each patient before performing this procedure

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Arroyo V et al. (1996) Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164–176

    Article  CAS  Google Scholar 

  2. Wong F et al. (1995) Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Intern Med 122: 816–822

    Article  CAS  Google Scholar 

  3. Salerno F et al. (2003) Humoral and cardiac effects of TIPS in cirrhotic patients with different 'effective' blood volume. Hepatology 38: 1370–1377

    PubMed  Google Scholar 

  4. Riggio O et al. (1996) Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Incidence and risk factors. Dig Dis Sci 41: 578–584

    Article  CAS  Google Scholar 

  5. Montgomery A et al. (2005) MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 28: 307–312

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor of Medicine and Chief of the Department of Internal Medicine,

    Francesco Salerno & Massimo Cazzaniga

  2. Assistant Professor of Medicine, at the Policlinico San Donato, University of Milan, Milan, Italy

    Francesco Salerno & Massimo Cazzaniga

Authors
  1. Francesco Salerno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Cazzaniga
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Salerno.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salerno, F., Cazzaniga, M. Transjugular intrahepatic portosystemic shunt or paracentesis for refractory ascites—which is best?. Nat Rev Gastroenterol Hepatol 3, 312–313 (2006). https://doi.org/10.1038/ncpgasthep0520

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0520

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing